Summarized Financial Information Concerning Reportable Segments |
Summarized financial information concerning reportable segments is shown in the following tables:
Three Months Ended June 30, 2021
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
16,347,880
|
|
|
$
|
1,447,001
|
|
|
$
|
35,709
|
|
|
$
|
17,830,590
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
17,382,292
|
|
|
|
1,450,332
|
|
|
|
-
|
|
|
|
18,832,624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(8,337,405
|
)
|
|
|
(2,794,219
|
)
|
|
|
(4,449,608
|
)
|
|
|
(15,581,232
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(78,793
|
)
|
|
|
(366
|
)
|
|
|
(3,244,912
|
)
|
|
|
(3,324,071
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(8,416,198
|
)
|
|
|
(2,794,585
|
)
|
|
|
(7,694,520
|
)
|
|
|
(18,905,303
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
1,055,537
|
|
|
|
268,927
|
|
|
|
1,530
|
|
|
|
1,325,994
|
|
Total assets
|
|
|
169,799,509
|
|
|
|
20,593,411
|
|
|
|
42,420,872
|
|
|
|
232,813,792
|
|
Three Months Ended June 30, 2020
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
6,502,865
|
|
|
$
|
1,249,020
|
|
|
$
|
35,709
|
|
|
$
|
7,787,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
12,237,141
|
|
|
|
1,258,488
|
|
|
|
-
|
|
|
|
13,495,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(12,852,835
|
)
|
|
|
(919,309
|
)
|
|
|
(3,351,681
|
)
|
|
|
(17,123,825
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(235,442
|
)
|
|
|
(33
|
)
|
|
|
(2,818,791
|
)
|
|
|
(3,054,266
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(13,088,277
|
)
|
|
|
(919,342
|
)
|
|
|
(6,170,472
|
)
|
|
|
(20,178,091
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
772,241
|
|
|
|
111,106
|
|
|
|
2,305
|
|
|
|
885,652
|
|
Total assets
|
|
|
109,105,418
|
|
|
|
7,542,486
|
|
|
|
74,893,664
|
|
|
|
191,541,568
|
|
Six Months Ended June 30, 2021
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
29,768,923
|
|
|
$
|
4,038,868
|
|
|
$
|
71,417
|
|
|
$
|
33,879,208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
32,832,049
|
|
|
|
3,770,697
|
|
|
|
-
|
|
|
|
36,602,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(17,843,093
|
)
|
|
|
(4,765,060
|
)
|
|
|
(8,137,328
|
)
|
|
|
(30,745,481
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(100,307
|
)
|
|
|
(750
|
)
|
|
|
(6,438,706
|
)
|
|
|
(6,539,763
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(17,943,400
|
)
|
|
|
(4,765,810
|
)
|
|
|
(14,576,034
|
)
|
|
|
(37,285,244
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
2,725,432
|
|
|
|
4,321,303
|
|
|
|
-
|
|
|
|
7,046,735
|
|
Depreciation and amortization expense
|
|
|
2,065,307
|
|
|
|
486,918
|
|
|
|
3,397
|
|
|
|
2,555,622
|
|
Six Months Ended June 30, 2020
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
14,246,139
|
|
|
$
|
3,669,782
|
|
|
$
|
71,417
|
|
|
$
|
17,987,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
26,689,094
|
|
|
|
3,635,761
|
|
|
|
-
|
|
|
|
30,324,855
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(25,328,980
|
)
|
|
|
(1,376,464
|
)
|
|
|
(7,188,167
|
)
|
|
|
(33,893,611
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(474,314
|
)
|
|
|
(33
|
)
|
|
|
(5,055,363
|
)
|
|
|
(5,529,710
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(25,803,294
|
)
|
|
|
(1,376,497
|
)
|
|
|
(12,243,530
|
)
|
|
|
(39,423,321
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
5,064,494
|
|
|
|
1,178,790
|
|
|
|
-
|
|
|
|
6,243,284
|
|
Depreciation and amortization expense
|
|
|
1,447,214
|
|
|
|
222,395
|
|
|
|
4,881
|
|
|
|
1,674,490
|
|
|